Loading insider details...
Beta
Latest Form 4 (May 21, 2024): Grant/Award of 990,000 RGLS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2024 | Regulus Therapeutics Inc. (RGLS) | Grant/Award | 990,000 | n/a |
| Jan 18, 2024 | Regulus Therapeutics Inc. (RGLS) | Sale | 14,580 | $17.4K |
| Jan 17, 2024 | Regulus Therapeutics Inc. (RGLS) | Grant/Award | 30,000 | n/a |
| May 23, 2023 | Aurinia Pharmaceuticals Inc. (AUPH) | Exercise/Conversion | 8,733 | n/a |
| May 20, 2022 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 8,733 | n/a |
| Jan 4, 2022 | Aurinia Pharmaceuticals Inc. (AUPH) | Exercise/Conversion | 40,000 | $203.2K |
| Jun 17, 2021 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 31,347 | n/a |